WELLS FARGO & COMPANY/MN

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 72971 SAN FRANCISCO, CA

Back to REGN Full portfolio

Position in REGN

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$109,731,102

+$1,631,483 QoQ

Shares Held

142,021

+1.4% QoQ

Ownership

0.135%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 97.83130663775076.ToString("F0")% Shared 0.ToString("F0")% None 2.168693362249245.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Mar 31, 2024

CallValue

CallShares

PutValue

$96,249

PutShares

100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,292,850,561 across 389 Biotechnology names. REGN ranks #3 (8.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	744,995	$332,670,066
2	ALNY	Alnylam Pharmaceuticals, Inc.	342,763	$113,409,991
3	REGN	Regeneron Pharmaceuticals, Inc. This page	142,021	$109,731,102
4	HALO	Halozyme Therapeutics, Inc.	1,535,737	$99,254,679
5	INSM	INSMED Inc	597,384	$97,684,229
6	ASND	Ascendis Pharma A/S	154,199	$35,269,936
7	EXEL	Exelixis, Inc.	687,304	$29,478,466
8	ARGX	Argenx SE	38,104	$27,825,444

All Filings in REGN

Export CSV

32 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$109,731,102	142,021	+1.4%	Shares	Defined	2026-05-11
2025-12-31	$108,099,619	140,049	+4.3%	Shares	Defined	2026-02-13
2025-09-30	$75,467,877	134,220	+0.1%	Shares	Defined	2025-11-13
2025-06-30	$70,377,300	134,052	-8.0%	Shares	Defined	2025-08-14
2025-03-31	$92,398,429	145,686	-4.5%	Shares	Defined	2025-05-13
2024-12-31	$108,636,021	152,508	-12.4%	Shares	Defined	2025-02-13
2024-09-30	$182,958,859	174,041	+11.2%	Shares	Defined	2024-11-13
2024-06-30	$164,524,030	156,536	+23.5%	Shares	Defined	2024-08-13
2024-03-31	$121,964,805	126,718	+126618.0%	Shares	Defined	2024-05-10
2024-03-31	$96,249	100	0.0%	Put	Defined	2024-05-10
2023-12-31	$87,829	100	-99.9%	Put	Defined	2024-02-09
2023-12-31	$104,019,395	118,434	+118334.0%	Shares	Defined	2024-02-09
2023-09-30	$82,296	100	-99.9%	Put	Defined	2023-11-13
2023-09-30	$95,927,508	116,564	+116464.0%	Shares	Defined	2023-11-13
2023-06-30	$71,854	100	-99.9%	Put	Defined	2023-08-15
2023-06-30	$101,123,725	140,735	+140635.0%	Shares	Defined	2023-08-15
2023-03-31	$82,167	100	0.0%	Call	Defined	2023-05-12
2023-03-31	$82,167	100	-99.9%	Put	Defined	2023-05-12
2023-03-31	$120,462,572	146,607	-6.6%	Shares	Defined	2023-05-12
2022-12-31	$113,257,332	156,977	+1625.0%	Shares	Defined	2023-02-13
2022-09-30	$6,268,717	9,100	-94.7%	Put	Defined	2022-11-14
2022-09-30	$117,885,631	171,129	-14.0%	Shares	Defined	2022-11-14
2022-06-30	$117,692,798	199,098	-12.8%	Shares	Defined	2022-08-12
2022-03-31	$159,456,268	228,310	+13.1%	Shares	Defined	2022-05-16
2021-12-31	$127,450,206	201,815	-25.1%	Shares	Defined	2022-02-14
2021-09-30	$163,145,028	269,581	-0.3%	Shares	Defined	2021-11-15
2021-06-30	$151,068,869	270,471	+0.7%	Shares	Defined	2021-08-16
2021-03-31	$127,020,581	268,463	-18.6%	Shares	Defined	2021-05-13
2020-12-31	$159,262,523	329,661	-8.4%	Shares	Defined	2021-02-09
2020-09-30	$201,511,841	359,984	+16.3%	Shares	Defined	2020-11-05
2020-06-30	$193,014,059	309,491	+38.4%	Shares	Defined	2020-08-13
2020-03-31	$109,184,572	223,606	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.